GlassScriptPhysician profile
Ruben Nunez
NPI 1669036661
$30,723.83
in general payments reported to CMS, 2019-2025
29 companies · $3,007 in 2025
The $3,007 reported for 2025 was more than what 89% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $250 · 2020: $598 · 2021: $4,458 · 2022: $11K · 2023: $8,115 · 2024: $3,369 · 2025: $3,007.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,512 · Travel and Lodging: $6,979.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,512.11 |
| Travel and Lodging | $6,979.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $9,805.83 | 2020-2025 | Inbone, Hoffmann, Salvation |
| Smith+Nephew, INC. | $5,180.66 | 2020-2025 | Taylor Spatial Frame, Salto Talaris Total Ankle Prosthesis, Oasis |
| Novus Surgical Solutions LLC | $4,086.40 | 2021-2022 | |
| Orthofix Medical, INC. | $2,862.61 | 2020-2022 | |
| Gemini Mountain Medical, LLC | $2,744.61 | 2022 | |
| Bioventus LLC | $1,376.31 | 2023 | Stimrouter Implantable Kit |
| Dne LLC | $619.20 | 2022 | |
| Avanos Medical | $569.04 | 2023-2025 | On-Q* Pump and Accessories, On-Q Pump and Accessories |
| Organogenesis INC. | $490.03 | 2020-2022 | |
| Abbvie INC. | $430.55 | 2022-2024 | |
| Horizon Therapeutics Plc | $363.06 | 2021-2023 | Krystexxa |
| Musculoskeletal Transplant Foundation INC. | $336.72 | 2021-2022 | |
| Kci USA, INC. | $264.07 | 2019-2022 | |
| Integra Lifesciences Corporation | $165.33 | 2022 | |
| Treace Medical Concepts, INC. | $148.63 | 2022-2025 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mimedx Group, INC. | $132.94 | 2024 | |
| Zimmer Biomet Holdings, INC. | $132.69 | 2020-2021 | |
| Averitas Pharma INC. | $131.20 | 2023 | Qutenza |
| Amgen INC. | $124.98 | 2024 | Krystexxa |
| Pacira Pharmaceuticals Incorporated | $124.80 | 2019 | |
| Spr Therapeutics, INC | $122.54 | 2024 | Sprint Pns System |
| Acumed LLC | $113.20 | 2025 | Acumed |
| Medtronic, INC. | $104.97 | 2024 | Hawkone |
| Medical Device Business Services, INC. | $96.42 | 2021 | |
| Alliance Medical | $84.05 | 2025 | |
| Nevro Corp. | $45.26 | 2022 | |
| Electronic Waveform Lab, INC. | $43.69 | 2023 | |
| Janssen Pharmaceuticals, INC | $15.16 | 2023 | Xarelto |
| Kerecis Limited | $8.88 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ruben Nunez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.